Form 8-K - Current report:
SEC Accession No. 0001628280-25-004293
Filing Date
2025-02-06
Accepted
2025-02-06 17:30:11
Documents
13
Period of Report
2025-01-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K snti-20250131.htm   iXBRL 8-K 28042
  Complete submission text file 0001628280-25-004293.txt   155084

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snti-20250131.xsd EX-101.SCH 1785
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT snti-20250131_lab.xml EX-101.LAB 22530
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snti-20250131_pre.xml EX-101.PRE 13045
16 EXTRACTED XBRL INSTANCE DOCUMENT snti-20250131_htm.xml XML 2926
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40440 | Film No.: 25598526
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)